Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023085 · ClinicalTrials.gov registry record · Phase 1
A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects
A Phase 1 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
NCT03023085: Completed Phase 1 study, sponsored by Braintree Laboratories.
NCT03023085 is a Phase 1 study that has completed, run by Braintree Laboratories. The registered enrollment target is 120 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (100% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03023085, a Phase 1 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.
Primary Outcome
% of subjects with successful bowel preparation rated by blinded colonoscopist on a 4 point scale (1=poor, 2=fair, 3=good, 4 = excellent)
Interventions
- DRUG BLI4700
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-08 |
| Phase | Phase 1 |
What the finished NCT03023085 record still lists
NCT03023085 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (100% higher).
The record links to 0 conditions, and to 1 intervention - of which BLI4700 is the first listed.
NCT03023085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03023085 about?
NCT03023085 is a clinical study titled "A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects". The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.
What is the current status of trial NCT03023085?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2016-08. Estimated completion is 2017-08.
What interventions are being tested in trial NCT03023085?
The interventions under investigation include: BLI4700 (DRUG).
Who is sponsoring clinical trial NCT03023085?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03023085's enrollment target sits among peer trials
120 479th of 2000 higher than 1,503 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia